Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes

Elucidation of physical-chemical characteristics of investigational medicinal products should be established with suitable methodology. Characterization of nanomedicines and nanocarriers in clinical trials may require the definition of additional specific properties depending on the nature of the na...

Descripción completa

Detalles Bibliográficos
Autores principales: Dri, Diego Alejandro, Rinaldi, Federica, Carafa, Maria, Marianecci, Carlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713170/
https://www.ncbi.nlm.nih.gov/pubmed/36450964
http://dx.doi.org/10.1007/s13346-022-01262-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713170/
https://www.ncbi.nlm.nih.gov/pubmed/36450964
http://dx.doi.org/10.1007/s13346-022-01262-y

Ejemplares similares